RVL Pharmaceuticals (NASDAQ:RVLP) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:50 AM.
Here's what investors need to know about the announcement.
Earnings
RVL Pharmaceuticals beat estimated earnings by 61.9%, reporting an EPS of $-0.08 versus an estimate of $-0.21.
Revenue was down $2.44 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 3.43% drop in the share price the next day.
Here's a look at RVL Pharmaceuticals's past performance:
Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
---|---|---|---|---|
EPS Estimate | -0.27 | -0.36 | -0.14 | -0.23 |
EPS Actual | -0.30 | -0.42 | -0.20 | -0.15 |
Revenue Estimate | 3.10M | 2.35M | 34.55M | 30.65M |
Revenue Actual | 2.86M | 2.20M | 11.51M | 23.88M |
To track all earnings releases for RVL Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.